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Post-antifungal effect (PAFE) of Candida and its production of hemolysin are determinants of candidal pathogenicity. Candida albicans is the foremost aetiological agent of oral 
candidosis, which can be treated with polyene, azole, and echinocandin antifungals. However, 
once administered, the intraoral concentrations of these drugs tend to be subtherapeutic 
and transient due to the diluent effect of saliva and cleansing effect of the oral musculature. 
Hence, intra-orally, Candida may undergo a brief exposure to antifungal drugs. Objective: 
Therefore, the PAFE and hemolysin production of oral C. albicans isolates following brief 
exposure to sublethal concentrations of the foregoing antifungals were evaluated. Material 
and Methods: A total of 50 C. albicans oral isolates obtained from smokers, diabetics, 
asthmatics using steroid inhalers, partial denture wearers and healthy individuals were 
exposed to sublethal concentrations of nystatin, amphotericin B, caspofungin, ketoconazole 
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production were determined by previously described turbidometric and plate assays, 
respectively. Results: Nystatin, amphotericin B, caspofungin and ketoconazole induced 
mean PAFE (hours) of  2.2, 2.18, 2.2 and 0.62, respectively. Fluconazole failed to produce 
a PAFE. Hemolysin production of these isolates was suppressed with a percentage reduction 
of 12.27, 13.47, 13.33, 8.53 and 4.93 following exposure to nystatin, amphotericin B, 
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to sublethal concentrations of antifungal drugs appears to exert an antifungal effect by 
interfering with the growth as well as hemolysin production of C. albicans.
Keywords: Candida albicans. Post-antifungal effect. Hemolysins. Antimycotics.
INTRODUCTION
Multiple physiognomies of Candida species 
have been suggested as virulence factors that 
enable the organism to cause superficial as 
well as disseminated infections in susceptible 
hosts11. Hemolysins are known to be critical 
virulent determinants contributing to candidal 
pathogenesis12. In particular, the secretion of 
hemolysin, followed by lysis of erythrocytes and 
subsequent acquisition of iron by Candida, facilitates 
hyphal invasion that contributes to the recalcitrance 
of the disease12,13. In Candida albicans, it has been 
shown that secretion of hemolytic factors causes 
the release of hemoglobin, which is then used as 
an iron source by the organism13. Others have 
proposed that hemoglobin is an important host 
factor that triggers a different metabolic pathway 
necessary for establishing disseminated infections 
by C. albicans14. For instance, adding hemoglobin 
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of the yeast to several host proteins. This activity 
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of hemoglobin is independent of iron acquisition, 
and is facilitated by a cell surface hemoglobin 
receptor. Furthermore, hemoglobin rapidly induces 
the expression of several genes, one of which, a 
heme oxygenase, allows the pathogen to consume 
exogenous heme or hemoglobin to acquire iron 
and produce the cytoprotective molecules14. Such 
exquisite recognition and responses to hemoglobin 
appear to be a unique adaptation of C. albicans to 
be a versatile opportunistic pathogen in the human 
host14.
C. albicans is by far the leading fungal 
pathogen of oral candidosis, the commonest 
human fungal infection with a variety of clinical 
manifestations9. Interestingly, more than 90% 
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individuals develop oral candidosis during some 
point of their disease which is arguably the 
commonest oral manifestation in such patients. In 
addition, C. albicans has also been implicated in oral 
candidosis in other patient groups such as diabetics, 
asthmatics using inhalation steroids, smokers and 
denture wearers10,16,17. Recent studies have also 
shown that C. albicans isolates from subgingival 
biofilms of immunocompromised patients also 
produce hemolysins which may also exacerbate 
periodontal disease in these patients by insidiously 
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destruction15.
Growth suppression of Candida that occurs 
subsequent to limited exposure to antifungal 
agents, as in the case of the oral environment, has 
been described as the post-antifungal effect (PAFE). 
It has been proposed that the knowledge of PAFE 
would be clinically useful in evaluating new dosage 
regimens of a drug, and such curtailment of growth 
following transient exposure to antifungal agents 
may be a determinant of candidal virulence itself, 
as this phenomenon may modulate the virulent 
attributes of the yeast Candida5.
A number of antifungal therapeutic agents are 
accessible for treatment of oral Candida infections. 
These include the two polyenes group agents, 
nystatin and amphotericin B, the echinocandin agent 
caspofungin and the azoles such as ketoconazole 
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the availability of these pharmacological agents 
for the management of oral candidosis, failure 
of therapy and ensuing recalcitrant infection is 
not uncommon9. One reason for this may be the 
distinctive nature of the oral milieu where the 
diluent effect of saliva and the cleansing effect of the 
oral musculature tend to reduce the bioavailability 
of antifungal agents below that of the effective 
therapeutic concentrations. Hence, intra-orally, 
the pathogenic Candida may undergo a transient 
exposure to an antifungal agent on administration, 
and subsequently the drug concentration is likely 
to be subtherapeutic5,9. Yet, the impact of such 
therapeutic levels of antifungals leading to PAFE 
and hemolysin production of oral C. albicans isolates 
obtained from different susceptible patient groups 
to oral candidosis (i.e., diabetics, asthmatics using 
inhalation steroids, smokers and partial denture 
wearers) has not been studied hitherto.
Hence, the main aim of this study was to 
determine the PAFE induced by five different 
antifungal agents belonging to three distinct classes, 
polyenes (nystatin, amphotericin B), echinocandins 
(caspofungin), and azoles (ketoconazole and 
	
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C. albicans isolates. The 
opportunity was also taken to evaluate candidal 
hemolysin production under identical conditions of 
drug exposure.
MATERIAL AND METHODS
Organisms
A total of 50 oral isolates of C. albicans obtained 
in a previous study from patients seeking treatment 
from the Kuwait University Dental Clinic were 
included in the current study (10 isolates each 
from smokers, diabetics, asthmatics using steroid 
inhalation, patients wearing partial acrylic dentures 
and healthy individuals)7. None of the patients from 
which the isolates were recovered had clinically 
visible oral candidosis. Initially, all Candida isolates 
were tested for germ tube formation. Thereafter 
the colony characteristics were observed using 
CHROMagar Candida medium (Becton Dickinson and 
$	"!J"#LJ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yeast ID system (BioMérieux, France) as well as 
API 20C AUX yeast ID system (BioMérieux, Inc, 
Hazelwood, MO, USA).
Antifungal agents and media
Nystatin, amphotericin B, ketoconazole 
and fluconazole (Sigma, St. Louis, MO, USA) 
were dissolved in dimethylsulphoxide (DMSO). 
Caspofungin (Merck and Company Inc, Waterhouse 
Station, NJ, USA) was dissolved in sterile distilled 
water. These anti-Candida agents were prepared 
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	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to each experiment as previously described4,5. It 
was thereafter suspended/diluted in the following 
medium during the exposure period of yeasts: RPMI 
(Roswell Park Memorial Institute) 1640 medium 
buffered with 0.165 M MOPS (3-(N-morpholino) 
propanesulfonic acid) containing L-glutamine and 
lacking sodium bicarbonate (Sigma, USA), dissolved 
in 1 liter of sterile distilled water and adjusted to a 
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
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Determination of minimal inhibitory 
concentration (MIC)
The susceptibility of the C. albicans isolates to 
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antifungal agents was determined as described in 
an earlier study of ours7. The MIC values against 
amphotericin B, caspofungin, ketoconazole and 
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according to  manufacturer’s recommendations (AB 
BIODISK, Solna, Sweden). As depicted in previously 
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uniformly suspended in sterile saline, and turbidity 
was adjusted to 0.5 McFarland Standard. The 
McFarland Standard 0.5 is approximately equal 
to 1x106 to 5x106 cells/ml3. This inoculum was 
swabbed onto the agar plates (150 mm diameter) 
and allowed to dry for 10-15 min before the E test 
strips were applied. RPMI 1640 agar supplemented 
with 2% glucose and buffered with MOPS (0.165 
}~ "< |?   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according to the method recommended by the 
CLSI (formerly National Committee for Clinical 
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incubated at 35°C, and MIC was observed after 
24–48 h of incubation. The point where inhibition 
ellipses intercepted the scale on the antifungal strip 
was taken as the MIC for each test isolate: complete 
inhibition (100%) of growth for amphotericin B 
and caspofungin, and marked decrease in growth 
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Reference strains of C. albicans, ATCC 90028, and 
C. parapsilosis, ATCC 22019, were used as reference 
strains. Interpretive susceptibility breakpoints for 
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susceptibility breakpoints for amphotericin B 
and ketoconazole, an isolate was considered 
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ketoconazole7. For caspofungin, isolates with MIC 
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As previously performed, the MIC values of 
nystatin were established by the broth dilution 
technique5 by performing two-fold serial dilutions 
of the drug in microtitre plates using an inoculum 
of 1-5×105 colony forming units (CFU)/ml. The MIC 
was determined visually following 24 h incubation 
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}=$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  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concentration of the drug that impeded growth 
of Candida cells, as indicated by the absence 
of turbidity (optically clear). The MIC was read 
independently by a couple of laboratory personals. 
C. albicans ATCC 90028 was used as a reference 
strain.
Preparation of cell suspension for the PAFE 
and hemolysin production assay
A heretofore explained method was used for 
this purpose4-6&!Candida cells maintained on 
Sabouraud Dextrose Agar (SDA), were inoculated 
onto fresh plates and incubated overnight at 37°C 
for 24 h prior to use. The organisms were harvested 
and a cell suspension prepared in sterile phosphate 
buffered saline (PBS) at 520 nm to an optical density 
of 1.5. From this cell suspension, 1 ml was added 
to tubes containing 4 ml of RPMI broth (control) 
and 4 ml of RPMI/drug solution (test), in which the 
drug concentration was twice the MIC. This gave 
a cell suspension of approximately 106 cells ml-1 in 
each assay tube. The tubes were then incubated at 
37°C for a period of 60 min. Following this limited 
exposure, the drugs were removed by two cycles 
of dilution with sterile PBS and centrifugation. 
Supernatant was thereafter completely decanted 
and the pellets were re-suspended in 2.5 ml 
of sterile PBS. This technique has been used 
previously for drug removal, and has revealed to 
minimize the concentration of the drug as much as 
10,000 fold, thus curtailing any carry-over effect 
of the drug following its removal3-5. Viable counts 
of the control and the test were performed after 
drug removal. As the procedure of drug removal 
effectively eliminated any carry-over effect, there 
was virtually no difference on the viable counts 
of the control and the tests following exposure to 
already diluted subtherapeutic concentrations of the 
drug, as observed in previous studies4-6.
PAFE assay
Following drug removal, in order to ascertain 
the growth suppression and ensue the recovery 
of fungal growth, namely the PAFE, the growth 
was determined by a previously described optical 
density method with minor amendments using the 
equation PAFE=T-C4-6. T is the time required for 
optical density of the drug-exposed cell suspension 
to reach the selected relative optical density of 0.05 
value at 520 nm. C is the time required for optical 
density of the drug-free control cell suspension to 
reach the selected relative optical density value at 
520 nm. Thus, T-C expresses the time in which the 
antifungal agent was capable of causing growth 
suppression of the organism following limited 
exposure to the drug (i.e., PAFE). As in previous 
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with 2.4 mL of RPMI 1640 at 37°C and the relative 
optical density of the suspension was measured at 
frequent intervals (i.e., 15 min) for 8 h by which 
time, both the controls and tests reached the 
selected relative optical density value, enabling to 
calculate the PAFE4-6.
Hemolysin assay
Hemolysin production was determined with 
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	*	"!"	!
described 1,12,13=	\]			
treated antifungal and control suspensions were 
spot-inoculated on a blood agar supplemented with 
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5.6±0.2. Spot-inoculation was performed to yield a 
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circular inoculation site of about 10 mm in diameter. 
The plates were then incubated at 37°C in 5% CO2 
for 48 h. After incubation during this period, the 
diameter of the colony (y) and the diameter of the 
colony plus the translucent zone of hemolysis (x) 
were measured. The ratio of x/y, which represents 
the hemolytic activity (hemolytic index), was 
measured as done previously1,12,13.
All experiments were repeated on three separate 
occasions with duplicate determinations on each 
occasion.
Statistical analysis
For the suppression effect on hemolysin 
production, the raw data did not follow normal 
distribution. Therefore, in accordance to  non-
parametric statistician advices, Wilcoxon Signed 
Ranks test was used to compare the control 
	"	 *	"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different antifungal agents. The difference between 
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
drugs were also compared using Wilcoxon Signed 
Ranks test in relation to drug-induced PAFE and 
suppression of hemolysin production. A p value 
of less than 0.05 was considered statistically 
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RESULTS
All C. albicans isolates were susceptible to the 
tested antifungal drugs. The MIC (]^?values of 
all C. albicans isolates for nystatin obtained from the 
broth dilution technique ranged between 0.78-1.56. 
The MIC values obtained by E-tests for amphotericin 
B were between 0.004-0.19, and for caspofungin it 
ranged between 0.004-0.125. Ketoconazole elicited 
a MIC of 0.004-0.032 while it ranged between 
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Based on the equation PAFE=T-C, the mean 
in vitro PAFE (hours) on 50 oral isolates of C. 
albicans following 1 h exposure and subsequent 
removal of nystatin, amphotericin B, caspofungin 
and ketoconazole was 2.20, 2.18, 2.20 and 
0.62, respectively (Table 1). Hence, in summary, 
brief exposure to nystain, amphotericin B and 
caspofungin was able to suppress the growth of C. 
albicans isolates giving a PAFE of approximately 2 h 
whereas it was approximately ½ h for ketoconazole. 
Fluconazole failed to elicit a detectable PAFE.
Mean hemolysin production (hemolytic index) 
of the 50 C. albicans isolates, following limited 
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of antifungal agents, drug removal and subsequent 
production of hemolysin production is shown in Table 
2. Mean hemolysin production of the unexposed 
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exposure to nystatin, amphotericin B, caspofungin, 
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1.37 and 1.42, respectively. Hence, as shown in 
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activity was observed following the exposure to all 
of these drugs, with a mean percentage reduction 
of 12.27, 13.47, 13.33, 8.53 and 4.93 for nystatin, 
amphotericin B, caspofungin, ketoconazole and 
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The analysis of the difference on PAFE and the 
suppressive effect on hemolysin production elicited 
+!  *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  revealed 
that the PAFE and the suppressive effect elicited 
by the polyene and echinocandin antifungal agents 
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addition, the PAFE and the hemolysin suppressive 
effect elicited by the two azoles were also 
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with ketoconazole having a superior effect than 
Source of C. albicans 
isolates (n=50)
Nystatin Amphotericin B Caspofungin Ketoconazole Fluconazole
Healthy (n=10)  2.21 (0.21) 2.18 (0.20) 2.22 (0.21) 0.65 (0.11) No detectable 
change in growth 
suppression
Diabetic  (n=10) 2.17 (0.21) 2.10 (0.19) 2.20 (0.20) 0.60 (0.09)
Asthmatic (n=10) 2.19 (0.19) 2.30 (0.13) 2.20 (0.20) 0.62 (0.09)
Smokers  (n=10) 2.20 (0.20) 2.22 (0.21) 2.21 (0.19) 0.63 (0.10)
Denture Wearers (n=10) 2.22 (0.22) 2.12 (0.21) 2.16 (0.18) 0.60 (0.09)
Mean (n=50) 2.2 2.18 2.2 0.62
SEM 0.02 0.02 0.02 0.002
SD 0.2 0.2 0.19 0.1
Table 1- The post-antifungal effect (PAFE) (in hours) of 50 oral C. albicans isolates following 1 hour exposure and subsequent 
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			C. albicans obtained either from 
healthy individuals, diabetic patients, asthmatic patients, smokers or denture wearers. Regarding PAFE, 0.25=15 minutes; 
0.50=30 minutes; 0.75=45 minutes; 1.0=60 minutes. SD: Standard deviation. SEM: Standard error of mean
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effect on hemolysin production elicited by the two 
polyenes and the echinocandin agent were not 
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Finally, when comparing the clinical isolates from 
diabetics, asthmatics, smokers, denture wearers 
and healthy individuals, there were no difference in 
either PAFE or hemolysin production on exposure to 
sublethal concentrations of any of the antifungals.
DISCUSSION
C. albicans is by far the major aetiological agent 
of oral candidosis8. Hemolysin is one of C. albicans 
recently recognized, putative virulent factors. In 
particular, the secretion of hemolysin facilitates 
hyphal invasion, which is critical for disseminated 
candidal infection1,12-14. As described above, it is 
known that PAFE, the capacity of Candida to recover 
and grow after an antifungal-insult, is another 
important measure of the virulence of the yeast4-7. 
We, along with others, have shown that more 
Source of C. 
albicans isolates 
(n=50)
Unexposed 
controls
Nystatin Amphotericin B Caspofungin Ketoconazole Fluconazole
Healthy 1.49 1.31 1.29 1.29 1.37 1.42
(n=10) -0.02 -0.02 -0.05 -0.05 -0.02 -0.02
Diabetic 1.5 1.3 1.27 1.3 1.38 1.43
(n=10) -0.03 -0.03 -0.06 -0.05 -0.03 -0.02
Asthmatic 1.5 1.33 1.31 1.32 1.38 1.43
(n=10) -0.02 -0.05 -0.07 -0.06 -0.03 -0.03
Smokers 1.51 1.34 1.33 1.29 1.36 1.43
(n=10) -0.02 -0.06 -0.07 -0.07 -0.02 -0.04
Denture Wearers 1.5 1.3 1.29 1.3 1.37 1.42
(n=10) -0.03 -0.07 -0.08 ().05) -0.03 -0.02
Mean  (n=50) 1.5 1.32 1.3 1.3 1.37 1.42
SEM 0.003 0.007 0.009 0.008 0.004 0.004
SD 0.02 0.05 0.06 0.06 0.03 0.03
p value p<0.001 p<0.001 p<0.001 p<0.001 p<0.001
Table 2-  Mean (SD) hemolysin activity (hemolytic index) of 50 oral C. albicans isolates following 1 hour exposure and 
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			C. 
albicans obtained either from healthy individuals, diabetic patients, asthmatic patients, smokers or denture wearers. SD: 
Standard deviation. SEM: Standard error of mean
Source of C. albicans 
Isolates (n=50)
Nystatin Amphotericin B Caspofungin Ketoconazole Fluconazole
Healthy 12.08 13.42 13.42 8.05 4.7
Diabetic 13.33 15.33 13.33 8 4.66
Asthmatic 11.33 12.66 12 8 4.66
Smokers 11.26 11.92 14.57 9.93 5.3
Denture Wearers 13.33 14 13.33 8.66 5.33
Mean 12.27 13.47 13.33 8.53 4.93
SEM 0.46 0.58 0.41 0.37 0.16
SD 1.02 1.3 0.91 0.83 0.35
Table 3- Summary of the mean percentage suppression of hemolysin activity in 50 oral C. albicans isolates following 1 hour 
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of hemolysin activity in 10 oral C. albicans obtained from either healthy individuals, diabetic patients, asthmatic patients, 
smokers or denture wearers. SD: Standard deviation. SEM: Standard error of mean
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virulent and resistant Candida will have a low PAFE, 
whereas susceptible and less virulent organisms will 
have higher PAFEs4-7.
The present results indicate that brief exposure 
to sublethal concentrations of nystatin, amphotericin 
B, caspofungin and ketoconazole elicited PAFEs 
ranging from approximately 30 to 120 min with 
the C. albicans isolates tested. A notable exception 
	
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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
tested isolates. The observed PAFE may be related 
to the pharmacodynamics of these antimycotics on 
Candida. For instance, both polyenes (nystatin and 
amphotericin B) bind to the sterol components in 
the yeast cell wall and make it more penetrable5,9. 
Furthermore, investigations have shown internally 
collapsed cells with an intact cell wall leaving 
“ghosts-like” cells, and deflated Candida cells 
following exposure to subcidal concentrations of 
polyenes8. Caspofungin, on the contrary, acts by 
inhibiting the enzyme responsible for biosynthesis 
	_\+!
of the fungal cell wall2. In addition, caspofungin 
has shown excellent growth-inhibitory activity 
against Candida at low concentrations2. As for 
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 
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alter the fungal cell membranes by blocking the 
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ergosterol. The consequent depletion of ergosterol 
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		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alterations in a number of membrane-associated 
functions4,9. Considering the foregoing wide range 
pharmacodynamic properties of the agents we 
have studied, it is tempting to speculate that the 
structural changes of the cell wall, as well as the 
metabolic effects elicited by the drugs, would all 
contribute to the suppression of growth eliciting 
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a detectable PAFE response in spite of this drug 
being remarkably more effective in vivo than 
ketoconazole in the management of candidal 
infection9. Interestingly, many workers have shown 
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C. albicans isolates in vitro is much less than that 
of ketoconazole4,9,18. Hence, the later could be one 
reason for the absence of detectable PAFE following 
'"			
	
The exposure of C. albicans isolates to the 
foregoing drugs was also capable of suppressing 
	! "		 	  ! 	 *
varying levels ranging from 5% to 13.5%. A 
previous single study has also shown a reduction 
of hemolysin activity of C. albicans, as well as 
Candida tropicalis isolates, following exposure to 
! "	 &  	
	1. It is 
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which these drugs modulate changes in hemolysin 
production in Candida species. However, taken 
collectively, *	+	
understanding of pharmacodynamics of these 
antifungal agents against two virulent determinants 
(i.e., PAFE and hemolysin production) incriminated 
in the pathogenesis of C. albicans infections. In 
addition, as hemolysins are known to mediate 
host invasion, particularly by facilitating hyphal 
penetration of the epithelium, it can be speculated 
that, by suppressing hemolysin production, these 
antifungals could also minimize yeast dissemination 
from and within the oral and periodontal tissues.
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polyenes and echinocandins and azoles, as well as 
their suppressive effect on hemolysin production 
of Candida, as seen in this study, may well be 
due to the differences in the pharmacodynamics 
of the different antimycotic groups. Polyenes and 
echinocandins are fungicidal against C. albicans 
whereas azoles are fungistatic9. This could be the 
foremost explanation for the exquisite sensitivity 
of C. albicans to nystatin, amphotericin B and 
caspofungin compared to the azoles. In addition, 
we also noted a significant difference in the 
PAFE and hemolysin production when the yeasts 
were exposed to the two azoles. As previously 
mentioned, others have shown that the growth 
+	!!		
	C. albicans 
in vitro is much less than that of ketoconazole4,9,18. 
These observations may be related to the fact that 
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is a triazole. Arguably, therefore, the differences in 
the mode of activity between the two azoles may 
		#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
variations in PAFE and hemolysin production.
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*
one to document the antifungal-induced PAFE 
using a wide array of antifungal agents and the 
suppression of hemolysin production during the 
PAFE period, covering the largest number (n=50) 
of oral C. albicans isolates obtained from a single 
geographic locale. Testing with a larger number 
of sessile isolates encased in a Candida +	*
scenario instead of using only planktonic isolates as 
used in this study is warranted to further elucidate 
*The exact cellular mechanisms 
by which antifungals interfere with hemolysin 
activity in Candida also remain to be elucidated.
CONCLUSIONS
Brief and transient exposure to sublethal 
concentrations of antifungal drugs may induce a 
PAFE and modulate hemolysin production of oral 
C. albicans isolates, thereby adversely affecting 
their pathogenic potency. The data herein also 
provide an insight into the possible mechanisms of 
antifungal agents, at subtherapeutic concentrations, 
in biological milieus such as the oral cavity.
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